RESEARCHER PROFILE

Li Li

← Back to Shanghai University

L

Shanghai University

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesGenetic factors in colorectal cancer

Li Li works in Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Head and Neck Cancer Studies, Genetic factors in colorectal cancer. Recorded institutional associations include BGI Group (China), Harbin University of Science and Technology, Wannan Medical College.

2,190Publications
13,909Citations
48H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. A Landscape of Driver Mutations in Melanoma

    2012 · 2,603 citations

  2. Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

    2019 · 679 citations

  3. Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression

    2015 · 553 citations

  4. Re-Evaluation of 6th Edition of AJCC Staging System for Nasopharyngeal Carcinoma and Proposed Improvement Based on Magnetic Resonance Imaging

    2009 · 290 citations

  5. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study

    2018 · 289 citations

  6. Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma

    2011 · 251 citations

  7. Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases

    2012 · 220 citations

  8. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer

    2010 · 214 citations

  9. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy

    2016 · 184 citations

  10. The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF

    2014 · 169 citations

  11. Sustainable Hard Carbon for Sodium‐Ion Batteries: Precursor Design and Scalable Production Roadmaps

    2025 · 156 citations

  12. Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial

    2022 · 151 citations

  13. Single‐cell analyses reveal suppressive tumor microenvironment of human colorectal cancer

    2021 · 145 citations

  14. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging

    2008 · 137 citations

  15. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1–T3 nasopharyngeal carcinoma – A case-matched comparison

    2015 · 133 citations

  16. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

    2017 · 130 citations

  17. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China

    2011 · 113 citations

  18. K63-Linked Ubiquitination in Kinase Activation and Cancer

    2012 · 110 citations

  19. Remodeling microenvironment based on MOFs-Hydrogel hybrid system for improving diabetic wound healing

    2021 · 96 citations

  20. Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging

    2013 · 93 citations

  21. Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma

    2019 · 93 citations

  22. In vitro and in vivo inhibitory effect of anthocyanin-rich bilberry extract on α-glucosidase and α-amylase

    2021 · 93 citations

  23. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy

    2021 · 92 citations

  24. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors

    2019 · 90 citations

  25. Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial

    2022 · 88 citations

← Return to the university profile